Skip to main content
. Author manuscript; available in PMC: 2010 Sep 22.
Published in final edited form as: Brain Res. 2009 Jul 16;1290:111–120. doi: 10.1016/j.brainres.2009.07.019

Fig. 3.

Fig. 3

Striatal ascorbate (AA) release in behaving mice. (A) Overall mean percent change in vehicle (VEH)-treated animals. R6/2 mice exhibited a diminished release of AA compared to wild-type (WT) mice (* p < 0.05 compared to R6/2 mice; n = 13 sessions in 11 WT mice and 15 sessions in 11 R6/2 mice). (B) Overall mean percent change in striatal AA release in amphetamine (AMPH)-treated animals. WT mice showed an increase in striatal AA release in response to AMPH that was not observed in R6/2 mice (* p < 0.05 compared to R6/2 mice; n = 14 WT mice and 12 R6/2 mice). (C) Mean percent change in striatal AA over time from baseline taken 5 min before injection of AMPH. WT mice increased AA release in response to AMPH, while R6/2 mice did not. (* p < 0.05 compared to R6/2 mice; n = 14 WT mice and 12 R6/2 mice).